Table 1 Outcome measures used in OptiTrain RCT at baseline and at 16 weeks, 1 year, 2 year and 5 years follow-up post-baseline.

From: Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer

Outcome

Tool used

Baseline

16 weeks post baseline

1 year post baseline

2 years post baseline

5 years post baseline

Cancer-related fatigue*

Swedish version of Revised Piper fatigue Scale (PFS) Swedish version44

×

×

×

×

×

Symptoms and symptom burden**

Swedish version of Memorial Symptom Assessment Scale (MSAS)45,46

×

×

×

×

×

Health-related quality of life**

Swedish version of European Organisation for Research and Cancer Treatment Quality of Life Questionnaire (EORTC-QLQ-C30) Version 3.047

×

×

×

×

×

Cardiorespiratory fitness**

Åstrand-Rhyming submaximal cycle test (Monark 928E, Monark Exercise AB, Vansbro, Sweden)48,49

×

×

×

×

×

Lower body muscle strength**

Isometric mid-thigh pull (Baseline leg dynamometer, Fabrication Enterprises Inc., White Plains, NY, USA)50

×

×

×

×

×

Upper body muscle strength**

Hand grip tests (JAMAR, SAEHAN corporation, Changwon, S. Korea)

×

×

×

×

×

Pressure Pain Threshold (PPT)**

Electronic algometer (Somedic Sales AB, Hörby, Sweden)51

×

×

×

×

Objective measures of Sedentary behaviour and physical activity**

Accelerometer (model GT3X ActiGraph® Corp, Pensacola, Florida, USA)22

×

×

×

Body mass**

Calibrated electric scales

×

×

×

×

×

Sick leave**

Single item study specific questionnaire

×

×

×

×

×

Heart failure diagnosis**

Swedish Heart Failure Registry18

×

Cognitive functioning**

Amsterdam Cognition Scan (ACS)19,20

×

  1. *Primary outcome; **Secondary outcomes.